TrialJournal of clinical hypertension (Greenwich, Conn.)2021

Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy.

Cesar A Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.